Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-14-016728
Filing Date
2014-03-04
Accepted
2014-03-04 17:19:56
Documents
2
Period of Report
2014-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2526
2 POA DOCUMENT poa.txt EX-24.3_511702 4121
  Complete submission text file 0001209191-14-016728.txt   8177
Mailing Address C?O GUILFORD PHARMACEUTICALS INC 6611 TRIBUTARY STREET BALTIMORE MD 21224
Business Address
Spengler William (Reporting) CIK: 0001297399 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36326 | Film No.: 14666081

Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 1 416-216-0000
Endo International plc (Issuer) CIK: 0001593034 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations